About us

What we do...

IMPROVE HEALTHCARE

Niropharm member organizations believe in working to improve healthcare indices and take active practical steps to support and be corporately responsible for the health of the citizens in very direct and tangible ways.

IMPACTFUL ADVOCACY

Actively advocates for transformative policies, innovation, and accessibility across the entire pharmaceutical value chain, ensuring sustainable healthcare solutions, regulatory compliance, and improved patient outcomes.

Pharma Marketing

Engage in strategic pharmaceutical marketing initiatives, ensuring widespread availability of high-quality medicines to meet the healthcare needs of Nigeria’s growing population efficiently and sustainably.

enhance quality

Dedicated to working to improve and enhance the quality of service to the Nation, public (local and international) Image, and the scope of the Nigerian Pharmaceutical Industry who face a number of challenges. 

TACKLE CHALLENGES

High cost of funds, Poor infrastructure & IPR protection, Chaotic drug distribution, Lack of data for planning, Counterfeiting, Low capacity of Regulatory Agencies, Regulatory Agency, not computerized, Poor surveillance

INDUSTRY COLLABORATION

NIROPHARM members collaborate with pharmaceutical organizations to build an efficient ecosystem, enhancing healthcare delivery, regulatory compliance, innovation, and medicine accessibility across Nigeria’s pharmaceutical industry.

EXECUTIVE TEAM.

YINKA SUBAIR
PRESIDENT
ADEMOLA ADEKUNKLE
VICE PRESIDENT
OSARETIN JAIYEOLA
FINANCIAL SECRETARY
ADEKUNLE ADESOYE
TREASURER
ARIT ONWUSAH
GENERAL SECRETARY
ANGELA ESSIEN
ASSISTANT GENERAL SECRETARY
MARY OGANGWU
PUBLICITY SECRETARY
NAVEEN PANA
EX-OFFICIO
SAMSON OGUNJINMI
EX-OFFICIO
OLUFEMI SOREMEKUN
IMMEDIATE PAST PRESIDENT
NIROPHARM is the Umbrella Body of Nigerian Representatives of Overseas Pharmaceutical Manufacturers, with a distinctive Research and Development Orientation that encompasses a wide variety of pharmaceutical marketing companies, but all with a common trait of representing one or many overseas pharmaceutical manufacturers.
We at the forefront of advocating and actively supporting tangibly improvement of the Pharma Sector in Drug Availability, Affordability, Distribution and Quality across the entire Pharma Value Chain. The pharma market in Nigeria is estimated to reach US\$1,839 million in 2025 (Source: Statista Market Forecast, Nigerian Pharmacies, 2025)
NIROPHARM It is responsible for a large percentage of Pharmaceuticals imported into, and in circulation in Nigeria and active in the News Media over issues relevant to the industry.

Imports of Pharmaceutical products constitute 70% of the Nigerian Pharma industry, while local Manufacture accounts for the remaining 30%.